Journal of Pain Research
Volume 13, 2020 - Issue
Open access
264
Views
6
CrossRef citations to date
0
Altmetric
Clinical Trial Report
Migraine-Specific Quality-of-Life Questionnaire (MSQ) Version 2.1 Score Improvement in Japanese Patients with Episodic Migraine by Galcanezumab Treatment: Japan Phase 2 Study
Mamoru Shibata1 Department of Neurology, Tokyo Dental College Ichikawa General Hospital, Ichikawa, Japan
, Tomomi Nakamura2 Medicines Development Unit Japan and Medical Affairs, Eli Lilly Japan K.K., Kobe, JapanCorrespondence[email protected]
, Akichika Ozeki2 Medicines Development Unit Japan and Medical Affairs, Eli Lilly Japan K.K., Kobe, Japan
https://orcid.org/0000-0001-5510-4219
Kaname Ueda2 Medicines Development Unit Japan and Medical Affairs, Eli Lilly Japan K.K., Kobe, Japan
https://orcid.org/0000-0003-1967-9829
Russell M Nichols3 Global Medical Affairs, Eli Lilly and Company, Indianapolis, IN, USA
https://orcid.org/0000-0001-7771-7366
Pages 3531-3538
|
Published online: 31 Dec 2020
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.